Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activities
Following is a summary of stock option activities for the year ended December 31, 2023:
Options Weighted
Average
Exercise Price
Weighted
Average
Grant Date
Fair Value
Weighted
Average
Remaining
Life
(years)
Intrinsic
Value
Outstanding – January 1, 2023 7,603,864  0.19  $ 0.21  4.6
Granted —  —  — 
Exercised (386,790) 0.18  0.22 
Forfeited —  —  — 
Outstanding – December 31, 2023
7,217,074  $ 0.19  $ 0.21  3.5 $ 24,119 
Exercisable as of December 31, 2023
7,217,074  $ 0.19  $ 0.21  3.5 $ 24,119 
Summary of Restricted Stock Activity

Restricted Stock Units
Weighted Average Grant Date
Fair Value
Non-vested – January 1, 2023 7,466,636  $ 5.52 
Granted
786,394  3.51 
Vested
(2,724,920) 5.96 
Forfeited
(268,128) 5.59 
Non-vested – December 31, 2023
5,259,982  $ 4.99 
Summary of Stock-based Compensation Expense
Stock-based compensation expense for stock options and restricted stock units in the consolidated statements of operations is summarized as follows:
For the Years Ended
December 31,
2023
December 31,
2022
Software development
$ 739  $ 941 
General and administrative(1)
13,849  9,142 
Selling and marketing
596  319 
Total stock-based compensation expense
$ 15,184  $ 10,402 
(1) The year ended December 31, 2023, includes an expense of $3,022 in connection with the equity-based portion of Trinity’s contingent consideration with a corresponding amount within accounts payable and accrued expenses, expected to be granted in 2024 in respect of 2023 results, offset by a credit of $339 in connection with the settlement of the equity-based portion of contingent consideration that was granted in the first quarter of 2023 in respect of 2022 results. The year ended December 31, 2022, included an expense of $2,125 in connection with the equity-based portion of Trinity’s contingent consideration , granted in the first quarter of 2023 in respect of 2022 results.